Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development
T-cell-dependent Antibody Responses and Immunopathology: A Comparative Study in Juvenile Cynomolgus Monkeys
Incidence of Neutralizing Adeno-Associated Viral Antibody Subtypes in Cynomolgus Monkeys of Cambodian, Mauritius, and Philippines Origins
Germline Integration Assessment in Preclinical Gene Therapy Studies
Key Considerations for Nonclinical AAV Gene Therapy Development
Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies